Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001398344-25-000246·111 Equity Group
Schedule 13D ownership disclosure
MATINAS BIOPHARMA HLDGS INC
Common Stock · CUSIP: 576810303
Event date: 2025-01-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Chaim Herzog
Shares: 263,000.00 · Class: 5.17%
- 111 Equity Group LLCReported CIK 0002024448
Shares: 248,000.00 · Class: 4.86%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001398344-25-000246
- Form type
- SCHEDULE 13D
- Filer
- 111 Equity Group
- CIK
- CIK 2024448
- Filed
- Jan 06, 2025
- Reporting period
- Jan 02, 2025
- Description
- Schedule 13D beneficial ownership